Less Ads, More Data, More Tools Register for FREE

DIRECTOR DEALINGS: Faron Pharmaceuticals Directors Buy Shares

Thu, 21st Jun 2018 16:31

LONDON (Alliance News) - Faron Pharmaceuticals Oy said on Thursday several directors purchased shares over the course of three days from Tuesday to Thursday.

On Tuesday, Non-Executive Director Matti Manner and a person closely associated purchased 22,900 shares in total at a price of 56 pence per share for GBP12,824.

On Wednesday, Chief Financial Officer Yrjo Wichmann bought 5,200 shares for 67 pence each for GBP3,484. On Thursday, Corporate Legal Counsel Pessi Honkasalo acquired 1,500 shares for 75p per share for GBP1,125.

Medical Director Matti Karvonon and a closely associated person purchased 15,000 shares at a price of 56p and 31,000 shares at 57p respectively on Thursday for GBP

Also on Thursday, Chief Executive Markku Jalkanen and a closely associated person bought a total of 36,000 shares for 71p, and Chief Development Officer Juho Jalkanen acquired 12,000 shares for the same price.

It has not been disclosed how many shares any of these directors now hold following these transactions.

Shares in the pharmaceutical company closed down 2.7% on Thursday at 72.00p.

Related Shares

More News
20 May 2024 09:03

Faron Pharma celebrates positive read-out in ongoing MDS trial

(Alliance News) - Faron Pharmaceuticals Ltd on Monday noted a positive read-out regarding the ongoing Bexmab trial on myelodysplastic syndrome, a form...

3 May 2024 13:39

TRADING UPDATES: Kelso raises stake in NCC; Transense joins project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Allia...

30 Apr 2024 16:33

Faron Pharmaceuticals extends funding agreement with IPF

(Sharecast News) - Faron Pharmaceuticals announced on Tuesday that it has extended its agreement with lender IPF to ensure continued financial support...

15 Apr 2024 10:58

Faron Pharmaceuticals reappoints former finance chief on interim basis

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing James O'Brien.

15 Apr 2024 09:36

Faron Pharmaceuticals CFO stands down

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.